With the increasing resistance of many Gram-negative bacteria to existing classes of antibiotics, identifying new paradigms in antimicrobial discovery is an important research priority. Of special interest are the proteins required for the biogenesis of the asymmetric Gram-negative bacterial outer membrane (OM). Seven Lpt proteins (LptA to LptG) associate in most Gram-negative bacteria to form a macromolecular complex spanning the entire envelope, which transports lipopolysaccharide (LPS) molecules from their site of assembly at the inner membrane to the cell surface, powered by adenosine 5′-triphosphate hydrolysis in the cytoplasm. The periplasmic protein LptA comprises the protein bridge across the periplasm, which connects LptB 2 FGC at the inner membrane to LptD/E anchored in the OM. We show here that the naturally occurring, insect-derived antimicrobial peptide thanatin targets LptA and LptD in the network of periplasmic protein-protein interactions required to assemble the Lpt complex, leading to the inhibition of LPS transport and OM biogenesis in Escherichia coli.
INTRODUCTION
The asymmetric outer membrane (OM) plays a critical role in protecting Gram-negative bacteria from extracellular cytotoxic molecules, including antibiotics. This unique bilayer comprises lipopolysaccharide (LPS) molecules in the outer leaflet and membrane glycerophospholipids in the inner leaflet. Integral OM proteins (OMPs) are crucial for the biogenesis of the OM, as well as for controlling the uptake and export of essential nutrients and signaling molecules across the OM. Of special interest are the seven proteins (LptA to LptG) needed to transport LPS molecules from their site of assembly at the inner membrane (IM), across the aqueous periplasm, to their final cell surface location during OM biogenesis (1) (2) (3) . The LptA to LptG proteins associate to form a macromolecular complex that spans the entire envelope (4, 5) . The periplasmic protein LptA, likely as a headto-tail oligomer, forms a protein bridge spanning the periplasm. LPS molecules are pushed across this bridge (6) (7) (8) (9) (10) , from LptB 2 FGC anchored in the IM to the LptDE complex embedded in the OM (Fig. 1A) (11) (12) (13) (14) (15) (16) , powered by adenosine 5′-triphosphate (ATP) hydrolysis in the cytoplasm (4) . We report here that the naturally occurring, insect-derived host-defense peptide thanatin (Fig. 1B) targets both LptA and LptD in Escherichia coli.
Thanatin was first isolated from the hemipteran insect Podisus maculiventris (spined soldier bug) in 1996 (17) . The peptide contains 21 amino acids (GSKKPVPIIYCNRRTGKCQRM) with a disulfide bond between Cys 11 and Cys 18 . Antimicrobial activity for thanatin was reported against E. coli, Salmonella typhimurium, Klebsiella pneumoniae, and Enterobacter cloacae with minimal inhibitory concentrations (MICs) of <1.5 M and with weaker activity against Erwinia carotovora and Pseudomonas aeruginosa (MICs of 10 to 12 M).
Although no activity was seen against Staphylococcus aureus, thanatin is active against some other Gram-positive bacteria with MICs of ≈1 to 5 M. Of special interest is the observation that the enantiomeric form (d-thanatin) loses much of its activity against all the Gram-negative strains tested, indicating a likely chiral target.
RESULTS

Mechanism of action
The mechanism of action of thanatin is so far unknown. The peptide is bactericidal against E. coli, shows only weak permeabilizing effects on the IM or OM, and does not cause hemolysis of blood erythrocytes even at 100× the MIC (17) (18) (19) (20) . We confirmed that thanatin has no membrane-permeabilizing effects on E. coli. The fluorescent dye SYTOX Green does not penetrate E. coli cells treated with thanatin even at 100 g/ml (see section S3). Moreover, no release into the external medium of ß-lactamase expressed in the periplasm or of ß-galactosidase expressed in the cytoplasm of E. coli could be detected upon exposure to thanatin (see Supplementary Materials). Thus, even at concentrations much higher than the MIC, neither the IM nor the OM of E. coli is permeabilized by treatment with thanatin, unlike what is seen with some other cationic antimicrobial peptides, such as polymyxin B, colistin, or protegrin I (21, 22) .
The effects of thanatin on macromolecule biosynthesis were examined by monitoring the incorporation of appropriate [ To analyze effects on morphology, we grew E. coli cells with thanatin at concentrations causing substantial growth inhibition and then examined them in thin sections by transmission electron microscopy (TEM). This revealed frequent defects in membrane architecture, with accumulations of membrane-like material inside cells (Fig. 2, A and B) . These multilayered membrane folds inside the cell are typical of those reported for E. coli in which LPS transport is inhibited by 2 of 8 down-regulation of LptA/B, LptC, or LptD (5, 16) . The effects of thanatin on E. coli were also monitored by laser scanning stimulated emission depletion (STED) fluorescence microscopy, with staining of membranes by the membrane dye FM4-64, of nucleoids by 4′,6-diamidino-2-phenylindole (DAPI), and using SYTOX Green to detect permeabilized cells (Fig. 2, C and D) . These studies revealed frequent accumulations of membrane-like material in the form of knobs stained bright red by FM4-64 and elongated cell assemblies, with neither effect visible in the absence of thanatin. Nucleoids stained with DAPI were not influenced significantly by thanatin, and again no significant staining was observed by SYTOX Green.
These results reveal that thanatin causes defects in the membrane assembly in E. coli.
A fluorescent derivative (thanatin-BDP-FL; MIC of ≈1 to 2 g/ml; Fig. 1B ) was used for STED fluorescence imaging. This probe stained the E. coli envelope, with marked focal accumulations (as green fluorescent knobs) across the cell and at the cell poles (Fig. 2E ). This behavior is reminiscent of fluorescent labeling of OMPs that accumulate into membrane islands or clusters and at the poles in Gram-negative bacteria (23, 24) . The interaction of thanatin with OMPs in E. coli was tested directly by photoaffinity labeling experiments. Two thanatin-derived photoprobes were synthesized containing photoproline (25, 26) , in place of either Pro 5 or Pro 7 , together with an N-terminal polyethylene glycol linker and biotin tag for pull-down assays (Fig. 1B and sections S2 and S5 ). Both probes (thanatin-PAL5 and thanatin-PAL7) maintained antimicrobial activity against E. coli ATCC 25922 (MICs of 2 to 4 g/ml) and photolabeled the same membrane proteins in vivo, as shown in Western blotting for thanatin-PAL5 in Fig. 3A . In a competitive photolabeling experiment with native thanatin (200 g/ml) as a competitor, thanatin-PAL5 (2 g/ml) labeling of the ≈95-kDa band largely disappeared from the blot, whereas the other signals showed reduced labeling (Fig. 3A) . When the in vivo photolabeled membrane protein extract was analyzed under nonreducing conditions to retain disulfide bonds, a shift of the ≈95-kDa band to ≈130 kDa was seen in the Western blot (Fig. 3B and the Supplementary Materials). This change in gel electrophoretic mobility is very characteristic of that reported for E. coli LptD in the disulfide-reduced and disulfide-oxidized forms (LptD ox ≈ 130 kDa and LptD red ≈ 90 kDa) (27, 28) .
It was technically not possible to identify photolabeled proteins directly from the Western blots. To identify thanatin interaction partners in a hypothesis-free, discovery-driven approach, we used the photoaffinity interaction mapping strategy outlined above, in combination with mass spectrometry (MS)-based proteomic analysis, which allows for the multiplexed and label-free quantification of E. coli interaction partners. Thanatin-PAL5-photolabeled and untreated control E. coli ATCC 25922 cells were lysed, and biotinylated proteins were purified using streptavidin-functionalized agarose resin. Enriched proteins were proteolytically digested and subsequently identified using high-performance liquid chromatography-tandem MS (HPLC-MS/MS). Four hundred proteins were identified at a false discovery rate (FDR) below 1%. Relative quantitative comparison revealed the specific and photolabeling-dependent enrichment of three proteins, namely, LptD, LptA, and BamB, of which LptD and LptA were the most significant (Fig. 3C ). Whereas photolabeling of the membrane protein LptD was already suggested by the Western blotting experiments described above, photolabeling of LptA, a small (≈18 kDa) soluble periplasmic component of the LPS transport pathway (Fig. 1A) , was unexpected.
Resistant mutants
Spontaneous thanatin-resistant (Than R ) mutants of E. coli ATCC 25922 were sought for genetic analysis. Than R mutants could be isolated at low frequency (≈1 in 10 8 colony-forming units (CFU); 10 −6 %) by passaging on Mueller-Hinton II (MH-II) agar containing thanatin (10 to 50 g/ml). Five Than R mutants were selected that remained stable over at least four passages on thanatin-free agar (see section S6). Three mutants showed no difference in growth behavior compared to the wild-type (WT) in MH-II media and no increased sensitivity on MH-II agar supplemented with 0.5% SDS and 1 mM EDTA. Also, the susceptibility of all mutants to a series of standard antibiotics was unchanged (see section S6). Whole-genome sequencing of the three Than R mutants revealed several mutations compared to the WT genome, including lptA as the only mutated gene common to all three. Moreover, one resistant mutant (Than R -8) contained only a single point mutation in the entire genome, corresponding to a change of glutamine to leucine at position 62 (Q62L) in LptA. We also tested whether the identified mutations Q62L-LptA and D31N-LptA would confer resistance to thanatin when introduced into a sensitive E. coli strain. For this, genes encoding LptA with a His6 tag at the C terminus (LptA-His6), as well as the corresponding mutated variants (Q62L-LptA-His6 and D31N-LptAHis6), were introduced into E. coli. Introduction of the mutant alleles led to a markedly higher MIC for thanatin, whereas introduction of the WT sequence (LptA-His6) gave no significant change in MIC (see section S6). In summary, the genetic and photolabeling results reveal a link between the antimicrobial activity of thanatin and LptA and point to LptA as an interaction partner for thanatin in E. coli. On the other hand, no mutations in lptD were detected in the genomes of the three analyzed Than R mutants.
In vitro binding studies
To date, no small molecules (apart from LPS) are known to interact with LptA, so we tested whether thanatin can directly bind to LptA in vitro. A recombinant full-length LptA [with a His6 tag fused to the C terminus (LptA-His6)] was produced in E. coli BL21(DE3) and purified to apparent homogeneity by SDS-PAGE after Ninitrilotriacetic acid affinity and anion exchange chromatography (see section S7). The binding of thanatin-BDP-FL (Fig. 1B) In control experiments using the enantiomeric form of thanatin (comprising all d-amino acids), no interaction of d-thanatin with LptA was observed by FP. The binding of thanatin to LptD was also measured in vitro using a recombinant His-tagged LptD/E complex purified from E. coli (see section S7.2). Using FP, thanatin-BDP-FL binds to LptD/E His with a K d of 34 ± 5 nM, whereas thermophoresis binding assays gave a K d of 44 ± 27 nM (see section S9). Thanatin therefore binds in vitro to both LptA and LptD/E in the low nanomolar range.
Nuclear magnetic resonance structural studies
To characterize the epitope on LptA involved in binding to thanatin, complex formation was monitored by [ 15 N, 1 H]-heteronuclear singlequantum coherence (HSQC) nuclear magnetic resonance (NMR) spectroscopy using a recently described, nonaggregating, truncated derivative of LptA called LptA m , lacking the last C-terminal ß-strand (10) . We confirmed in vitro that thanatin binds with the same high affinity also to LptA m (see section S8). Therefore, the lack of the last C-terminal ß-strand in this LptA m construct, which is important to prevent unwanted aggregation, does not affect binding to thanatin. This result is understandable, as we show later that thanatin interacts with the N-terminal ß-strands of LptA (vide infra). [ , with the strand orientation being defined by multiple interstrand NOEs (Fig. 4B) . ) is mostly solvent exposed (Fig. 4, A to C , are buried in the hydrophobic interior of the ß-jellyroll (Fig. 4A) , which in turn packs against a loop of the ß-jellyroll containing Gln 62 (Fig. 4C ). This proximity might explain why mutations at Asp ). This loop is missing in the x-ray structure of free LptA (9) ).
DISCUSSION
It has been shown that LptA can form head-to-tail homodimers in vivo, although it remains possible that a single LptA molecule can bridge the periplasm by contacting both LptC and N-LptD ( Fig. 1)  (7) . Furthermore, the known crystal structure of an LptA head-totail oligomer [Protein Data Bank (PDB) 2R1A] reveals the N-terminal ß-strands of one subunit interacting with the C-terminal strands of the next LptA subunit (9) . This interaction is likely important in assembling the LptA protein bridge across the periplasm in the macromolecular Lpt complex (Fig. 1A) . In addition, the N-terminal strands of LptA mediate the binding of LptA to the membraneanchored LptC (Fig. 1) (7, 9, 29, 30 ). The NMR structure of LptA complexed with thanatin, reported here, superimposed upon the crystal structure of the LptA head-to-tail oligomer (PDB 2R1A), reveals that the thanatin binding site overlaps and would therefore block the interaction between LptA subunits (Fig. 4D) . It also seems likely that thanatin will inhibit the LptA/C protein-protein interaction. Last, the C-terminal strands of LptA bind to the N-terminal ß-strands in the periplasmic ß-jellyroll domain of LptD. It is intriguing that the structure of the N-terminal ß-strands of the ß-jellyroll in LptD is highly similar to those in LptA (14, 15) . Residues in LptA that contact thanatin in the complex are highly conserved in the same positions in LptD (see section S10 and fig. S12 ). This strongly suggests that thanatin should interact with the N-terminal ß-strands in the ß-jellyroll of LptD/E. This implies that thanatin should also inhibit the interaction of LptA with LptD. Reported affinities of the LptA-LptA and LptA-LptC interactions have K d s in the low micromolar range (8, 31) . The nanomolar affinity of thanatin to both LptA and LptD reported here, therefore, appears strong enough to inhibit multiple protein-protein interactions required for the assembly of the LPS trans-periplasmic protein complex. These results highlight a new paradigm for an antibiotic action, targeting a dynamic network of protein-protein interactions required for assembly of the Lpt complex in E. coli. The results also identify one naturally occurring peptide as a starting point for the development of potential clinical candidates that target dangerous Gram-negative bacterial pathogens. Last, this work may also contribute to a better understanding of the biological function of thanatin in its natural context: controlling titers of symbiotic or invading bacterial pathogens in the midgut of various insect species (32) .
MATERIALS AND METHODS
Peptide synthesis
Methods of synthesis and analytical data for all peptides are included in the Supplementary Materials.
Methods for fluorescence and electron microscopy
Methods for fluorescence microscopy and TEM have been described in detail previously (24) .
Photoaffinity labeling E. coli ATCC 25922 cells grown in MH-I broth (50 ml) to an OD 600 (optical density at 600 nm) of 1.0 were collected, washed once, taken up in phosphate-buffered saline (PBS) (50 ml), and incubated for 30 min at 37°C with shaking at 200 rpm in the dark with thanatin-PAL5 (2 to 10 g/ml). Photoactivation was achieved by ultraviolet irradiation at 350 nm in a Rayonet Reactor (16 × 8-W Sylvania blacklight lamps) for 30 min at 30°C. Cells were then collected and washed two times with PBS. Cell pellets can be stored at −20°C. The cell pellet was resuspended in 50 mM tris-HCl (pH 7. 50 mM tris-HCl (pH 7.3) and collected again by ultracentrifugation (1 hour, 4°C).
Identification of photolabeled proteins by MS
Photolabeled and PBS-washed E. coli were lysed in 50 mM ammonium bicarbonate (AmBic) containing protease inhibitor cocktail (catalog no. 11704900, Roche) and 0.1% RapiGest (catalog no. 186002122, Waters) by six intervals of 30-s ultrasound sonication in a vial tweeter (Hielscher Ultrasonics GmbH) at a power of 170 W and 80% cycle time. Protein concentration was determined by a NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific Inc.), and 10 mg of protein was incubated with 200 l of streptavidin agarose resin (catalog no. 53116, Thermo Fisher Scientific) for 100 min at 4°C to bind biotinylated proteins. Beads were settled by centrifugation at 2000g for 5 min and transferred to Mobicol columns equipped with a 30-m pore size filter (MoBiTec GmbH). Beads were extensively washed with 5 M NaCl, StimLys buffer [50 mM tris (pH 7.8), 137 mM NaCl, 150 mM glycerol, 0.5 mM EDTA, 0.1% Triton X-100], 100 mM NaHCO 3 , and AmBic to remove nonbiotinylated proteins. Beadbound proteins were reduced with 5 mM tris(2-carboxyethyl) phos phine in AmBic for 40 min at 37°C, alkylated with 10 mM iodoacetamide in AmBic for 30 min at 37°C, and proteolytically digested by sequencing-grade modified trypsin (catalog no. V511A, Promega) at an enzyme-to-protein ratio of 1:100 for 20 hours at 37°C. Released peptides were acidified and subjected to C18 purification using UltraMicroSpin Columns (The Nest Group).
Peptide samples were separated by reversed-phase chromatography on an HPLC column (75-m inner diameter, New Objective) that was packed in-house with a 15-cm stationary phase (ReproSil-Pur C18-AQ, 1.9 m) and connected to a nanoflow HPLC with an autosampler (EASY-nLC 1000, Thermo Fisher Scientific). The HPLC was coupled to a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific) equipped with a nanoelectrospray ion source (Thermo Fisher Scientific). Peptides were loaded onto the column with 100% buffer A [99.9% H 2 O, 0.1% formic acid (FA)] and eluted at a constant flow rate of 300 nl/min with a 30-min linear gradient from 6 to 20% buffer B (99.9% MeCN and 0.1% FA) followed by a 15-min transition from 20 to 32% buffer B. Electrospray voltage was set to 2 kV, sheath and auxiliary gas flow to zero, and capillary temperature to 250°C. In data-dependent acquisition (DDA) mode, the mass spectrometer automatically switched between precursor and fragment ion detection. Following a high-resolution survey mass spectrum [from 300 to 1500 mass/charge ratio (m/z)] acquired in the Orbitrap with resolution R = 70,000 at m/z 200 (automatic gain control target value 3 × 10 6 ), the 15 most abundant peptide ions with a minimum intensity of 2.5 × 10 4 were selected for subsequent higherenergy collisional dissociation fragmentation with an isolation window of 1.4 Da, and fragments were detected by MS/MS acquisition in the Orbitrap at resolution R = 35,000 (automatic gain control target value of 1 × 10 6 ). Target ions already selected for fragmentation were dynamically excluded for 30 s.
Acquired raw files were subjected to protein identification using Comet (v.2015.01) and Trans Proteomic Pipeline v.4.7 (Seattle Proteome Center/Institute of Systems Biology, Seattle) by matching ion spectra acquired in the DDA mode against a SwissProt (UniProt consortium)-reviewed E. coli protein database (downloaded November 2016). Peptides were required to be fully tryptic with a maximum of two missed cleavage sites, carbamidomethylation as a fixed modification and methionine oxidation as a dynamic modification. The precursor and fragment mass tolerance were set to 20 parts per million (ppm) and 0.02 Da, respectively. Identified proteins were quantified by integration of chromatographic traces of peptides using Progenesis QI v.2.0 (Nonlinear Dynamics, UK). Contaminant hits were removed, and proteins were filtered to obtain an FDR of <1%. Raw protein abundances based on nonconflicting peptides were exported, and differential abundance testing was performed using R package MSstats v3.5.3 (33) . Significantly enriched E. coli proteins (abundance fold change ≥ 2 and adjusted P values of ≤0.05) were considered as bona fide thanatin-PAL5-binding candidates. Mass spectrometric data were deposited to the ProteomeXchange Consortium (www.proteomexchange.org/) via the PRIDE partner repository (data set identifier: PXD010988).
Thanatin-resistant E. coli mutants E. coli ATCC 25922 was grown in MH-II broth (20 ml) to OD 600nm = 1 at 37°C with 200 rpm shaking. This bacterial culture (100 l, corresponding to ≈5 × 10 7 CFU) was plated onto MH-II agar plates containing thanatin (10 to 50 g/ml) and incubated at 37°C overnight. Growing colonies were then passaged at least four times over MH-II plates without selection on thanatin, and then MIC values against thanatin were determined. Two independent experiments were performed. Of the initial 10 isolates, the mutants Than R -2, Than R -4, Than Final NMR samples contained 50 mM sodium phosphate, 150 mM NaCl (pH 7.5), and protein/peptide concentrations of 0.5 to 0.6 mM.
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NMR spectra were acquired at 290 K (free 15 N-thanatin) and at 308 K (free 15 N, 13 C LptA m , and complex of LptA m -thanatin) using 700-and 600-MHz Bruker NEO spectrometers. All spectra were processed using TopSpin 4.0 and analyzed using CARA and CCPNmr. The 1 H, 15 N, and 13 C chemical shifts of backbone and side-chain atoms were assigned using a standard set of triple-resonance experiments on either uniformly 15 We noticed that resonances from the presumably unstructured C-terminal tail including the His tag (residues 144 to 170) and some residues in the longer loop regions (6-7) were often missing, likely because of accelerated amide proton exchange at pH 7.5. To this end, we adjusted the sample of the LptA-thanatin complex to pH 4.6 and remeasured the triple-resonance spectra. The overall signal dispersion in the [ 15 N, 1 H]-HSQC spectra was not changed significantly, indicating a stable complex formation under those conditions. Additional amide cross peaks could be assigned to residues located in solvent-exposed loops or strands, namely, Gly H}-NOEs, indicating that they belonged to flexible amide moieties but could not be assigned unambiguously.
H and H chemical shifts obtained from the HBHA(CO)NH experiment were used in combination with C/C chemical shifts from the backbone assignments to obtain side-chain assignments in HCCH experiments. The aromatic side chains were linked to the backbone using the (HB)CB(CGCDCD)HD and (HB)CB(CGCDC-DCE)HE experiments (35) . The assignment of thanatin resonances in the complex was performed in a similar manner. Proton chemical shifts were referenced to the water line at 4.65 ppm at 308 K, from which the nitrogen and carbon scales were derived indirectly by using the conversion factors of 0.10132900 ( Upper-distance restraints used for the structure calculations of the LptA m -thanatin complex were generated from 70-ms (36) . The solution structure of the LptA m -thanatin complex was determined using distance restraints derived from a set of NOESY spectra and torsion angle restraints derived from TALOS+. A full description of the structure calculations and statistical analysis of results is given in the Supplementary Materials.
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